Fairpointe Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q3 | – | Sell |
-214,129
| Closed | -$15.1M | – | 78 |
|
|
2015
Q2 | $15.1M | Sell |
214,129
-60,560
| -22% | -$4.26M | 0.21% | 50 |
|
|
2015
Q1 | $21.8M | Sell |
274,689
-1,240,367
| -82% | -$98.3M | 0.29% | 50 |
|
|
2014
Q4 | $96.4M | Sell |
1,515,056
-165,860
| -10% | -$10.6M | 1.27% | 39 |
|
|
2014
Q3 | $100M | Buy |
1,680,916
+222
| +0% | +$13.3K | 1.34% | 40 |
|
|
2014
Q2 | $90M | Buy |
1,680,694
+123,118
| +8% | +$6.59M | 1.2% | 40 |
|
|
2014
Q1 | $94M | Sell |
1,557,576
-461,828
| -23% | -$27.9M | 1.28% | 41 |
|
|
2013
Q4 | $107M | Sell |
2,019,404
-330,238
| -14% | -$17.5M | 1.56% | 35 |
|
|
2013
Q3 | $109M | Buy |
2,349,642
+45,034
| +2% | +$2.08M | 1.83% | 28 |
|
|
2013
Q2 | $94.6M | Buy |
+2,304,608
| New | +$94.6M | 1.9% | 26 |
|